Mobileye Global Valuation
Is MBLY * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of MBLY * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: MBLY * (MX$265.99) is trading below our estimate of fair value (MX$581.98)
Significantly Below Fair Value: MBLY * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for MBLY *?
Other financial metrics that can be useful for relative valuation.
| What is MBLY *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$10.04b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 4.8x |
| Enterprise Value/EBITDA | -68.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does MBLY *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.4x | ||
NEMAK A Nemak S. A. B. de C. V | 0.06x | 3.1% | Mex$6.2b |
GISSA A Grupo Industrial Saltillo. de | 0.3x | 9.7% | Mex$6.0b |
7259 Aisin | 0.3x | 3.4% | JP¥1.3t |
TIINDIA Tube Investments of India | 4.9x | -6.4% | ₹830.1b |
MBLY * Mobileye Global | 5.4x | 19.4% | Mex$10.0b |
Price-To-Sales vs Peers: MBLY * is expensive based on its Price-To-Sales Ratio (5.4x) compared to the peer average (1.4x).
Price to Earnings Ratio vs Industry
How does MBLY *'s PE Ratio compare vs other companies in the Global Auto Components Industry?
Price-To-Sales vs Industry: MBLY * is expensive based on its Price-To-Sales Ratio (5.4x) compared to the Global Auto Components industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is MBLY *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 5.4x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate MBLY *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$265.99 | Mex$450.21 +69.3% | 28.7% | Mex$698.50 | Mex$252.24 | n/a | 26 |
| Sep ’25 | Mex$265.99 | Mex$483.65 +81.8% | 33.2% | Mex$981.98 | Mex$255.31 | n/a | 26 |
| Aug ’25 | n/a | Mex$641.36 0% | 22.6% | Mex$994.92 | Mex$412.99 | n/a | 26 |
| Jul ’25 | n/a | Mex$692.92 0% | 16.6% | Mex$973.86 | Mex$404.25 | n/a | 25 |
| Jun ’25 | n/a | Mex$651.90 0% | 18.4% | Mex$950.35 | Mex$373.35 | n/a | 26 |
| May ’25 | n/a | Mex$652.49 0% | 18.6% | Mex$953.12 | Mex$374.44 | n/a | 26 |
| Apr ’25 | n/a | Mex$635.69 0% | 21.2% | Mex$964.63 | Mex$365.89 | n/a | 25 |
| Mar ’25 | n/a | Mex$660.03 0% | 21.4% | Mex$989.86 | Mex$375.47 | n/a | 23 |
| Feb ’25 | n/a | Mex$669.06 0% | 21.3% | Mex$998.91 | Mex$378.90 | n/a | 23 |
| Jan ’25 | n/a | Mex$842.74 0% | 13.3% | Mex$1,226.33 | Mex$630.20 | n/a | 24 |
| Dec ’24 | n/a | Mex$840.54 0% | 13.4% | Mex$1,233.50 | Mex$633.88 | n/a | 24 |
| Nov ’24 | n/a | Mex$884.20 0% | 13.7% | Mex$1,303.67 | Mex$669.94 | n/a | 24 |
| Oct ’24 | n/a | Mex$853.62 0% | 13.5% | Mex$1,263.97 | Mex$596.88 | n/a | 24 |
| Sep ’24 | n/a | Mex$812.49 0% | 13.5% | Mex$1,206.71 | Mex$569.84 | Mex$265.99 | 23 |
| Aug ’24 | n/a | Mex$808.69 0% | 13.5% | Mex$1,201.06 | Mex$567.17 | n/a | 23 |
| Jul ’24 | n/a | Mex$814.79 0% | 13.0% | Mex$1,212.43 | Mex$683.06 | n/a | 21 |
| Jun ’24 | n/a | Mex$818.24 0% | 15.1% | Mex$1,253.85 | Mex$600.43 | n/a | 21 |
| May ’24 | n/a | Mex$822.83 0% | 16.1% | Mex$1,272.93 | Mex$609.57 | n/a | 19 |
| Apr ’24 | n/a | Mex$899.15 0% | 19.7% | Mex$1,462.09 | Mex$645.60 | n/a | 17 |
| Mar ’24 | n/a | Mex$873.52 0% | 19.4% | Mex$1,413.40 | Mex$624.10 | n/a | 17 |
| Feb ’24 | n/a | Mex$843.00 0% | 20.6% | Mex$1,444.47 | Mex$637.82 | n/a | 16 |
| Jan ’24 | n/a | Mex$846.71 0% | 25.2% | Mex$1,521.26 | Mex$632.21 | n/a | 14 |
| Dec ’23 | n/a | Mex$804.54 0% | 28.4% | Mex$1,474.99 | Mex$651.29 | n/a | 11 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.